Sanoptis is an innovative European ophthalmology services group, covering the full spectrum of diagnostic and surgical ophthalmic treatments
Sanoptis has raised $269.7M in total funding. The most recent round was Private Equity. The last funding was announced in March 2025.
Sanoptis's investors include The Carlyle Group.
Sanoptis is headquartered in Pfaffikon, Switzerland.
Sanoptis is an innovative European ophthalmology services group, covering the full spectrum of diagnostic and surgical ophthalmic treatments
Sanoptis is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sanoptis — Funding & Investors." VCBacked, March 25, 2025, https://www.vcbacked.co/company/sanoptis. Accessed November 13, 2026.
VCBacked. (2025). Sanoptis — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/sanoptis
{{cite web |title=Sanoptis — Funding & Investors |url=https://www.vcbacked.co/company/sanoptis |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sanoptis? Request a listing update